Thomas Daniel-Robin

Thomas Daniel-Robin has been the Head of Business Development and Partnerships of Orano Med since May 2023 in charge of driving the growth strategy and securing strategic partnerships to support the development of innovative treatments. With 18 years of experience in business development and managing strategic partnerships, he has developed strong expertise in the pharmaceutical industry. He started his career in 2007 at Genzyme as a Business Development Analyst and then a Project Manager and, before joining AdhexPharma in 2010 as the Director of Business Development and Head Project Management, a position he held for over six years. In 2016, he joined Genethon where he established a partnership with Sarepta Therapeutics and later moved to Vivet Therapeutics in 2017, where he led the establishment of strategic partnerships in the gene therapy field, notably with Pfizer and Mirum Pharmaceuticals. 

Thomas Daniel-Robin is a graduate of Institut Agro Rennes-Angers (Agronomy Engineer) and ESCP Business School (Master in Corporate Finance).